Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-07 Myszkowski Kenneth Allen Chief Financial Officer Sale 10b5-1 −10,000 $19.69 $197K 455,433
2025-01-06 Hamilton James C Chief Discovery/Trans Medicine Sale 10b5-1 −21,758 $19.68 $428K 283,093
2025-01-06 Hamilton James C Chief Discovery/Trans Medicine Sale 10b5-1 −10,971 $20.11 $221K 272,122
2025-01-06 O'Brien Patrick COO and General Counsel Sale 10b5-1 −19,658 $19.69 $387K 544,727
2025-01-06 O'Brien Patrick COO and General Counsel Sale 10b5-1 −9,526 $20.10 $191K 535,201
2025-01-06 Myszkowski Kenneth Allen Chief Financial Officer Sale 10b5-1 −17,765 $19.68 $350K 482,835
2025-01-06 Myszkowski Kenneth Allen Chief Financial Officer Sale 10b5-1 −9,402 $20.10 $189K 473,433
2025-01-02 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −11,520 $19.05 $219K 3,764,252
2024-12-27 OLUKOTUN ADEOYE Y Director Sale 10b5-1 −2,850 $20.00 $57K 36,740
2024-12-23 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −12,563 $19.59 $246K 3,775,772
2024-12-18 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −12,653 $20.52 $260K 3,702,394
2024-12-18 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −8,260 $21.74 $180K 3,694,134
2024-12-18 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −5,799 $22.12 $128K 3,688,335
2024-12-17 Waddill William D. Director Sale 10b5-1 −3,747 $22.04 $83K 40,378
2024-12-17 GIVEN DOUGLAS B Director Sale 10b5-1 −547 $22.04 $12K 124,167
2024-12-16 Waddill William D. Director Sale 10b5-1 −3,748 $21.90 $82K 44,125
2024-12-16 GIVEN DOUGLAS B Director Sale 10b5-1 −5,000 $21.90 $110K 124,714
2024-12-16 Vakiener Victoria Director Sale 10b5-1 −8,994 $21.91 $197K 21,211
2024-07-02 Oliver Tracie Chief Commercial Officer Sale 10b5-1 −9,394 $25.28 $237K 127,107
2024-05-02 Vakiener Victoria Director Sale 10b5-1 −1,799 $23.31 $42K 30,205

Page 5 of 23 · 444 trades